Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

(2011) Miguel Lozano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM

(2011) Johannes Irsch et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis

(2011) Laurence Corash   Expert Review of Hematology

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

(2010) Jean-Pierre Cazenave et al.   TRANSFUSION

Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction

(2010) Susanne M. Picker et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

Existence of a microRNA pathway in anucleate platelets

(2009) Patricia Landry et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Proteomic analysis of β-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway

(2009) Philippe Chafey et al.   PROTEOMICS

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use

(2009) Jean Claude Osselaer et al.   TRANSFUSION

Emerging infectious disease agents and their potential threat to transfusion safety

(2009) Susan L. Stramer et al.   TRANSFUSION

The platelet storage lesion

(2009) Manisha Shrivastava   TRANSFUSION AND APHERESIS SCIENCE

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

(2009) S. M. Picker et al.   VOX SANGUINIS

Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment

(2008) Fabrice Cognasse et al.   TRANSFUSION

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

(2008) Jean C. Osselaer et al.   TRANSFUSION

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

(2008) J. C. Osselaer et al.   VOX SANGUINIS